- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q4 (20) | 329.12 | 15.79 | 25.85 | 0 | 0 | 0 | 12.86 | 19.29 | 9.17 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.91 | 3.03 | -13.25 | 0.00 | 0 | 0 | 5266 | -3.8 | -3.8 |
| 24Q3 (19) | 284.25 | -19.64 | -17.09 | 0 | 0 | 0 | 10.78 | 2.28 | 6.84 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.79 | 27.27 | 28.86 | 0.00 | 0 | 0 | 5474 | 0.0 | -6.81 |
| 24Q2 (18) | 353.7 | -11.88 | 13.47 | 0 | 0 | 0 | 10.54 | 6.04 | -1.59 | 0 | 0 | 0 | 0.00 | 0 | 0 | 2.98 | 20.33 | -13.27 | 0.00 | 0 | 0 | 5474 | 0.0 | -6.81 |
| 24Q1 (17) | 401.39 | 53.48 | 26.75 | 0 | 0 | 0 | 9.94 | -15.62 | 4.52 | 0 | 0 | 0 | 0.00 | 0 | 0 | 2.48 | -45.02 | -17.54 | 0.00 | 0 | 0 | 5474 | 0.0 | -6.81 |
| 23Q4 (16) | 261.52 | -23.72 | -0.32 | 0 | 0 | 0 | 11.78 | 16.75 | -10.08 | 0 | 0 | 0 | 0.00 | 0 | 0 | 4.50 | 53.05 | -9.79 | 0.00 | 0 | 0 | 5474 | -6.81 | -6.81 |
| 23Q3 (15) | 342.83 | 9.98 | 11.92 | 0 | 0 | 0 | 10.09 | -5.79 | -3.54 | 0 | 0 | 0 | 0.00 | 0 | 0 | 2.94 | -14.34 | -13.81 | 0.00 | 0 | 0 | 5874 | 0.0 | -8.15 |
| 23Q2 (14) | 311.71 | -1.57 | 44.65 | 0 | 0 | 0 | 10.71 | 12.62 | 20.47 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.44 | 14.41 | -16.72 | 0.00 | 0 | 0 | 5874 | 0.0 | -8.15 |
| 23Q1 (13) | 316.67 | 20.7 | 1.4 | 0 | 0 | 0 | 9.51 | -27.4 | -3.06 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.00 | -39.85 | -4.4 | 0.00 | 0 | 0 | 5874 | 0.0 | -8.15 |
| 22Q4 (12) | 262.36 | -14.35 | -27.54 | 0 | 0 | 0 | 13.1 | 25.24 | 19.63 | 0 | 0 | 0 | 0.00 | 0 | 0 | 4.99 | 46.23 | 65.12 | 0.00 | 0 | 0 | 5874 | -8.15 | -8.15 |
| 22Q3 (11) | 306.33 | 42.16 | 2.08 | 0 | 0 | 0 | 10.46 | 17.66 | 8.17 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.41 | -17.23 | 5.97 | 0.00 | 0 | 0 | 6395 | 0.0 | -2.77 |
| 22Q2 (10) | 215.49 | -31.0 | -34.1 | 0 | 0 | 0 | 8.89 | -9.38 | -12.76 | 0 | 0 | 0 | 0.00 | 0 | 0 | 4.13 | 31.33 | 32.4 | 0.00 | 0 | 0 | 6395 | 0.0 | -2.77 |
| 22Q1 (9) | 312.29 | -13.76 | -29.37 | 0 | 0 | 0 | 9.81 | -10.41 | 0.82 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.14 | 3.88 | 42.75 | 0.00 | 0 | 0 | 6395 | 0.0 | -2.77 |
| 21Q4 (8) | 362.1 | 20.66 | -20.08 | 0 | 0 | 0 | 10.95 | 13.24 | -14.32 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.02 | -6.16 | 7.21 | 0.00 | 0 | 0 | 6395 | -2.77 | -2.77 |
| 21Q3 (7) | 300.09 | -8.23 | -17.29 | 0 | 0 | 0 | 9.67 | -5.1 | 30.85 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.22 | 3.41 | 58.21 | 0.00 | 0 | 0 | 6577 | 0.0 | -3.39 |
| 21Q2 (6) | 327.02 | -26.04 | -20.88 | 0 | 0 | 0 | 10.19 | 4.73 | 3.77 | 0 | 0 | 0 | 0.00 | 0 | 0 | 3.12 | 41.6 | 31.16 | 0.00 | 0 | 0 | 6577 | 0.0 | -3.39 |
| 21Q1 (5) | 442.17 | -2.41 | 28.9 | 0 | 0 | 0 | 9.73 | -23.87 | 1.14 | 0 | 0 | 0 | 0.00 | 0 | 0 | 2.20 | -21.98 | -21.53 | 0.00 | 0 | 0 | 6577 | 0.0 | -3.39 |
| 20Q4 (4) | 453.1 | 24.88 | 0.0 | 0 | 0 | 0.0 | 12.78 | 72.94 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 2.82 | 38.49 | 0.0 | 0.00 | 0 | 0.0 | 6577 | -3.39 | 0.0 |
| 20Q3 (3) | 362.84 | -12.22 | 0.0 | 0 | 0 | 0.0 | 7.39 | -24.75 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 2.04 | -14.27 | 0.0 | 0.00 | 0 | 0.0 | 6808 | 0.0 | 0.0 |
| 20Q2 (2) | 413.34 | 20.5 | 0.0 | 0 | 0 | 0.0 | 9.82 | 2.08 | 0.0 | 0 | 0 | 0.0 | 0.00 | 0 | 0.0 | 2.38 | -15.28 | 0.0 | 0.00 | 0 | 0.0 | 6808 | 0.0 | 0.0 |
| 20Q1 (1) | 343.03 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 9.62 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 2.80 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 6808 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 (10) | 1368.47 | 11.01 | 0 | 0 | 44.13 | 4.85 | 0 | 0 | 0.00 | 0 | 3.22 | -5.55 | 0.00 | 0 | 5266 | -3.8 |
| 2023 (9) | 1232.73 | 12.43 | 0 | 0 | 42.09 | -0.4 | 0 | 0 | 0.00 | 0 | 3.41 | -11.41 | 0.00 | 0 | 5474 | -6.81 |
| 2022 (8) | 1096.47 | -23.4 | 0 | 0 | 42.26 | 4.24 | 0 | 0 | 0.00 | 0 | 3.85 | 36.08 | 0.00 | 0 | 5874 | -8.15 |
| 2021 (7) | 1431.39 | -8.96 | 0 | 0 | 40.54 | 2.35 | 0 | 0 | 0.00 | 0 | 2.83 | 12.42 | 0.00 | 0 | 6395 | -2.77 |
| 2020 (6) | 1572.32 | -12.17 | 0 | 0 | 39.61 | -1.79 | 0 | 0 | 0.00 | 0 | 2.52 | 11.83 | 0.00 | 0 | 6577 | -3.39 |
| 2019 (5) | 1790.22 | 6.66 | 0 | 0 | 40.33 | 5.3 | 0 | 0 | 0.00 | 0 | 2.25 | -1.27 | 0.00 | 0 | 6808 | -7.29 |
| 2018 (4) | 1678.44 | -9.27 | 0 | 0 | 38.3 | -4.63 | 0 | 0 | 0.00 | 0 | 2.28 | 5.11 | 0.00 | 0 | 7343 | -60.27 |
| 2017 (3) | 1849.87 | 6.27 | 0 | 0 | 40.16 | -4.92 | 0 | 0 | 0.00 | 0 | 2.17 | -10.53 | 0.00 | 0 | 18483 | -9.08 |
| 2016 (2) | 1740.76 | 7.68 | 0 | 0 | 42.24 | 2.45 | 0 | 0 | 0.00 | 0 | 2.43 | -4.86 | 0.00 | 0 | 20328 | -0.55 |
| 2015 (1) | 1616.62 | 4.48 | 0 | 0 | 41.23 | 9.74 | 0 | 0 | 0.00 | 0 | 2.55 | 0 | 0.00 | 0 | 20440 | 9.47 |
